Clinical Trial Update: 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men [Phase 2]

View source ↗

Summary

This update reports the completion of a 28-day Phase 2 trial evaluating testosterone co-administered with dutasteride in men with hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• TESTOSTERONE (testosterone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypogonadism, Hypogonadism, Male | Phase 2 | Status: COMPLETED